| Literature DB >> 28962487 |
Alaa El-Din H Sayed1, Remon M Zaki2, Adel M Kamal El-Dean2, Abdullah Y Abdulrazzaq2.
Abstract
Synthesis of bi functionally substituted thieno[2,3-c]pyrazole compounds was carried out by a new method. The substituted group at position five is namely (carbonitrile, carboxamide, N-(substitutedphenyl) carboxamide and benzoyl group). Chloroacetylation of the amino thieno[2,3-c]pyrazolecarboxamide compound afforded the chloroacetyl amino derivative. The chemical structure of the newly synthesized compounds was established by elemental and spectral analysis including IR, 1H NMR spectra in addition to 13C NMR and mass spectra for most of them. In the present work, we assessed the role of the new synthesized thieno[2,3-c]pyrazole compounds as antioxidants against the toxicity of the 4-nonylphenol on the red blood cells of the most economically important Nile fishes namely African catfish (Clarias gariepinus). The erythrocytes alterations were used as biological indicators to detect those effects. After exposure to 4-nonylphenol, the erythrocytes malformations (swelled cells, sickle cells, tear drop like cells, acanthocytes, and vacuolated cells) were recorded in highest number in comparison with other groups control and those injected with thieno[2,3-c]pyrazole compounds. So, the new thieno[2,3-c]pyrazole compounds can be used as antioxidants against toxicity of 4-nonylphenol on fishes.Entities:
Keywords: Clarias gariepinus; RBCs; Synthesis; Thienopyrazole; Thienopyrazolopyrimidine
Year: 2015 PMID: 28962487 PMCID: PMC5598507 DOI: 10.1016/j.toxrep.2015.10.008
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
The fish groups exposed to 4-nonyphenol (0.1 mg/l), chemicals compounds (10 mg/kg body weight) and their combinations.
| Group | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| Treatment | |||||||
| 4-Nonylphenol | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 4-Amino-3-methyl-1-phenyl-1 | 0 | 0 | 10 | 0 | 0 | 0 | 0 |
| 4-Amino-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 10 | 0 | 0 | 0 |
| 4-Amino-N-(4-methoxyphenyl)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 0 | 10 | 0 |
| 4-Amino-N-(4-chlorophenyl)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
| 4-(2-Chloroacetamido)-3-methyl-1-phenyl-1 | 0 | 0 | 0 | 0 | 0 | 0 | 10 |
Altered erythrocytes in the African Catfish Clarias gariepinus exposed to 4-nonylphenol in combination with thieno[2,3-c]pyrazole compounds. The data are presented as means ± S.E. (range). N = 9.
| Parameters | Control | 4-Nonyl phenol | 4-Nonylphenol with amino-carbonitrile | 4-Nonylphenol with amino carboxamide | 4-Nonylphenol with amino- | 4-Nonylphenol with amino- | 4-Nonylphenol with 4-(2-chloroacetamido)-3-methyl-1-phenyl-1 |
|---|---|---|---|---|---|---|---|
| Altered erythrocytes % | 1 ± 0.3 | 40.3 ± 4.87 | 12 ± 1.03 | 0.6 ± 0.16 | 28.3 ± 2.04 | 3.7 ± 0.37 | 29.1 ± 3.05 |
| (03)d | (1262)a | (518)c | (01)d | (1537)b | (25)cd | (1443)b |
The physical properties of compounds (6af) and (7af).
| Compound no. | (6af) and (7af) | ||||||
|---|---|---|---|---|---|---|---|
| Mol. formula | M.P. | Solvent of crystallization | C | H | N | S | |
| 6a | C13H10N4S | 7880 | Ethanol | 61.40 | 3.96 | 22.03 | 12.61 |
| 61.15 | 4.10 | 21.93 | 12.75 | ||||
| 6b | C13H12N4OS | 144146 | Ethanol | 57.34 | 4.44 | 20.57 | 11.77 |
| 57.26 | 4.50 | 20.60 | 11.60 | ||||
| 6c | C19H16N4OS | 128130 | Ethanol | 65.50 | 4.63 | 16.08 | 9.20 |
| 65.72 | 4.55 | 15.95 | 9.40 | ||||
| 6d | C20H18N4OS | 118120 | Ethanol | 66.28 | 5.01 | 15.46 | 8.85 |
| 66.08 | 4.95 | 15.35 | 8.68 | ||||
| 6e | C20H18N4O2S | 148150 | Ethanol | 63.47 | 4.79 | 14.80 | 8.47 |
| 63.55 | 4.70 | 14.77 | 8.32 | ||||
| 6f | C19H15ClN4OS | 132134 | Ethanol | 59.60 | 3.95 | 14.63 | 8.37 |
| 59.80 | 3.90 | 14.70 | 8.50 | ||||
| 7a | C13H10N4S | 198200 | Ethanol +Dioxane | 61.40 | 3.96 | 22.03 | 12.61 |
| 61.30 | 3.90 | 22.16 | 12.52 | ||||
| 7b | C13H12N4OS | 214216 | Ethanol +Dioxane | 57.34 | 4.44 | 20.57 | 11.77 |
| 57.30 | 4.40 | 20.55 | 11.67 | ||||
| 7c | C19H16N4OS | 202204 | Ethanol +Dioxane | 65.50 | 4.63 | 16.08 | 9.20 |
| 65.76 | 4.50 | 16.15 | 9.35 | ||||
| 7d | C20H18N4OS | 200202 | Ethanol +Dioxane | 66.28 | 5.01 | 15.46 | 8.85 |
| 66.10 | 4.90 | 15.50 | 8.75 | ||||
| 7e | C20H18N4O2S | 208210 | Ethanol +Dioxane | 63.47 | 4.79 | 14.80 | 8.47 |
| 63.42 | 4.85 | 14.60 | 8.55 | ||||
| 7f | C19H15ClN4OS | 204206 | Ethanol +Dioxane | 59.60 | 3.95 | 14.63 | 8.37 |
| 59.70 | 4.00 | 14.57 | 8.41 | ||||
Spectral analysis of compounds 6af and 7af.
| Compound No. | IR (KBr, cm1) | 1H NMR, 13C NMR (ppm) | Mass spectra |
|---|---|---|---|
| 6a | ν: 3035 (CH aromatic), 29852925 (CH aliphatic), 2275, 2227 (2CN) cm1 | 1H NMR: (90 MHz, DMSO-d6) δ:2.85 (s, 3H, CH3), 3.85 (s, 2H, CH2), 7.607.40 (m, 5H, ArH) ppm | EI-MS ( |
| 6b | ν: 3450, 3300 (NH2), 3050 (CH aromatic), 2920, 2850 (CH aliphatic), 2210 (CN), 1660 (CO amide), 1590 (C = N) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.35 (s, 3H, CH3), 3.30 (s, 2H, CH2), 7.15 (s, 2H, NH2 disappeared by D2O), 7.307.70 (m, 5H, ArH) ppm | EI-MS ( |
| 6c | ν: 3160 (NH), 3057 (CH aromatic), 2920.81,2885 (CH aliphatic), 2227 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.56 (s, 3H, CH3), 4.03 (s, 2H, CH2), 7.087.52 (m, 10H, ArH), 10.15 (s,H,NH) ppm. | |
| 6d | ν: 3130 (NH), 3070 (CH aromatic), 2905, 2885 (CH aliphatic), 2220 (CN), 1660 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.31 (s, 3H, CH3 | |
| 6e | ν: 3303 (NH), 3035 (CH aromatic), 2975, 2870 (CH aliphatic), 2229 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.52 (s, 3H, CH3pyrazole), 3.75 (s,3H, CH3 | |
| 6f | ν: 3303 (NH), 3035 (CH aromatic), 2975, 2870 (CH aliphatic), 2229 (CN), 1654 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.32 (s, 3H, CH3), 3.70 (s, 2H, CH2), 7.337.99 (m, 9H, ArH), 10.28 (s,H,NH) ppm. | |
| 7a | ν: 3455, 3359, 3200 (NH2), 3045 (CH aromatic), 2950, 2890 (CH aliphatic), 2184 (CN) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 3.37 (s, 3H, CH3), 6.93 (s, 2H, NH2), 7.26-7.56 (m, 5H, ArH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 13.0 (CH3pyrazole), 71.22, 116.32, 140.79, 143.72, 147.79 (C), 117.16 (CN), 121.57, 125.98, 129.95, 138.31 (Phpyrazole) ppm. | ESI-MS: (C13H10N4S), 254.33 (M+) |
| 7b | ν: 3400, 3305, 3190 (2NH2), 3050 (CH aromatic), 2910(CH aliphatic) cm1, 1635 (CO amide), 1580 (C = N) cm1 | 1H NMR: (90 MHz, DMSO-d6) δ: 2.60 (s, 3H, CH3), 6.90 (s, 2H, NH2 amide), 7.0 (s, 2H, NH2), 7.30-7.70 (m, 5H, ArH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 15.2 (CH3pyrazole), 109.3, 121.5, 145.4, 145.4, 149.9 (C), 124.4, 128.2, 129.8, 133.1 (Phpyrazole), 169.8 (CONH2). | |
| 7c | ν: 3304, 3200 (NH2), 3135 (NH), 3050 (CH aromatic), 2006, 2887 (CH aliphatic), 1685 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.63 (s, 3H, CH3), 6.64 (s, 2H, NH2), 7.108.03 (m, 9H, ArH), 8.89 (s, H, NH) ppm | |
| 7d | ν: 3289, 3215 (NH2), 3130 (NH), 3070 (CH aromatic), 2905, 2885 (CH aliphatic), 1655 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.30 (s, 3H, CH3 p-tolyl), 2.63(s,3H,CH3pyrazole) 6.64 (s, 2H, NH2), 7.30-7.58 (m, 9H, ArH), 8.84 (s, H, NH) ppm | |
| 7e | ν: 3429, 3328, 3274.74 (2NH2, NH), 3030 (CH aromatic), 2860(CH aliphatic), 1624 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.48 (s, 3H, CH3pyrazole), 3.71 (s, 3H, CH3 | |
| 7f | ν: 3429, 3336, 3275 (2NH2, NH), 3050 (CH aromatic), 2880(CH aliphatic), 1640 (CO) cm1 | 1H NMR: (400 MHz, DMSO-d6) δ: 2.49 (s, 3H, CH3), 7.25 (s, 2H, NH), 7.317.71 (m, 9H, ArH), 9.37 (s, H, NH) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 13.1 (CH3pyrazole), 71.4, 116.3, 147.8, 156.0 (C), 121.0, 129.34, 132.7, 136.0 ( |
Scheme 1Synthesis of 4-amino-3-methyl-5-substituted-1-phenyl-1H-thieno[2,3-c]pyrazoles (7af).
Fig. 1Blood film of control catfish Clarias gariepinus showing the rounded shape of the nucleated erythrocytes (Er) and leucocytes (L). (H&E, ÿ400).
Fig. 2Blood film of catfish Clarias gariepinus treated with 1 mg/l 4-nonylphenol: (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr) (H&E, ÿ400).
Fig. 3Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbonitrile: (7a) (a) & (b) showing swelled cells (Sc), sickle cells (Sk), acanthocytecrenated cells (Ac) and cells have prominent vacuoles (Va). (H&E, ÿ400).
Fig. 4Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (7b) showing normal erythrocytes with presence of few numbers of sickle cells (Sk). (H&E, ÿ400).
Fig. 5Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus 4-amino-3-methyl-N-phenyl- p-chlorophenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (VIIf) showing normal erythrocytes with presence of few numbers of sickle cells (Sk). (H&E, ÿ400).
Fig. 6Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus: 4-amino-3-methyl-1-phenyl-N-p-anisyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (7e) (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr). (H&E, ÿ400).
Fig. 7Blood film of catfish Clarias gariepinus treated with 4-nonylphenol plus 4-(2-chloro-acetylamino)-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carboxamide (8): (a) & (b) showing swelled cells (Sc), sickle cells (Sk) and tear drop like cells (Tr). (H&E, ÿ400).